Delenex Therapeutics
Latest round
- Series A
Last raised
- Oct 2013
Total raised
- $41M
Investors
- 6
About Delenex Therapeutics
Founded in 2009 and based in Zurich, Switzerland, Delenex Therapeutics AG operates as a biotechnology company. The firm focuses on research and development of therapeutic antibody fragments targeting serious medical diseases.
Who invested in Delenex Therapeutics
6 investors across 3 rounds
See all investors in Delenex Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Delenex Therapeutics
Who invested in Delenex Therapeutics?
Delenex Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Delenex Therapeutics raised?
Delenex Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Delenex Therapeutics last raise money?
Delenex Therapeutics's most recent round on record is a Series A, in Oct 2013.
What does Delenex Therapeutics do?
Founded in 2009 and based in Zurich, Switzerland, Delenex Therapeutics AG operates as a biotechnology company.
Where is Delenex Therapeutics headquartered?
Delenex Therapeutics is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Delenex Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Delenex Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Delenex Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.